4th Quarter - Report

ABIOMED, INC for ABIOMED, INC

Firm
Client
Income
—
Expenses
$70,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

- Issues related to promoting competitiveness of the medical technology industry and the impact of federal policies. - H.R. 160, (Protect Medical Innovation Act), S. 149 (Medical Device Access and Innovation Protection Act)and provisions related to repeal of the medical device excise tax. - S.1077 Advancing Breakthrough Devices for Patients Act of 2015, provisions relating to breakthrough pathway.

LobbyistCovered position, as disclosed
MELISSA DODSON SCHOOLEY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1077 (114th), H.R. 160 (114th), S. 149 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.